Premium
Donor‐derived tuberculosis ( TB ): isoniazid‐resistant TB transmitted from a lung transplant donor with inadequately treated latent infection
Author(s) -
Jensen T.O.,
Darley D.R.,
Goeman E.E.,
Shaw K.,
Marriott D.J.,
Glanville A.R.
Publication year - 2016
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/tid.12580
Subject(s) - medicine , isoniazid , latent tuberculosis , tuberculosis , lung , pulmonary tuberculosis , complication , immunology , mycobacterium tuberculosis , surgery , pathology
Donor‐derived tuberculosis ( TB ) is an increasingly recognized complication of solid organ transplantation. We report a case of isoniazid‐resistant pulmonary TB in a lung transplant recipient. The patient acquired the infection from the lung donor who was previously empirically treated with isoniazid for latent TB . The case highlights the caveat that, while adequate treatment of latent TB with isoniazid is presumed, meticulous screening of donors is required.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom